#FGBlog: Telephone clinics in gastroenterology: here to stay?

Making changes within the NHS can feel complex and lumbering. The COVID-19 pandemic has accelerated change, with specialist units needing to demonstrate agility and innovation in ensuring patient access to services. Whilst doctors and patients alike may have found the pace of change hard to navigate, it is important to take stock and evaluate whether […]

Read More…

Rational Investigations in IBS

Reassurance is an interesting concept in modern medicine. I remember my blood pressure creeping up at the sight of an advert on the tube a few years back for a health check involving a ‘whole body MRI scan,’ fuming over the willingness of this private healthcare provider to offer false assurance of alleviating any anxiety […]

Read More…

Treat to target in IBD? Should this be part of an individualised treatment plan?

Acceptability of a ‘treat to target’ approach in inflammatory bowel disease to patients in clinical remission 1. Christian Selinger1,2, 2. Jenelyn Carbonell1, 3. John Kane1, 4. Mandour Omer1, 5. Alexander Charles Ford1,2 Historically the goal in inflammatory bowel disease was to enable the patient to have absence of symptoms, ideally in the absence of requiring […]

Read More…

Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up audit

Porter, R.J., McKinlay, A.W. and Metcalfe, E.L. Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up audit. Frontline Gastroenterology. 2019 Nov 13. http://dx.doi.org/10.1136/flgastro-2019-101306   Gastrostomy, the process in which the stomach is anchored to the abdominal wall and a gastrostomy tract […]

Read More…